Author

Robyn Leonard

Observed name: R. Leonard

Institution: Canadian Partnership Against Cancer

Observed institutions: BC Cancer Agency, The University of Sydney, University of Waterloo, Canadian Partnership Against Cancer, Cooperative Trials Group for Neuro-Oncology, National Health and Medical Research Council

ORCID: 0000-0003-4454-7617

Observed ORCID: 0000-0003-4454-7617

OpenAlex ID: A5015030511

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study

2021 · Hao-Wen Sim, Kerrie L McDonald, et al. · Neuro-Oncology · 105

PDF

[ 18 F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial

2023 · Eng-Siew Koh, Hui K Gan, et al. · BMJ Open · 27

PDF

Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review

2021 · George N Okoli, Otto L T Lam, et al. · BMJ Open · 20

PDF

A Canadian National Expert Consensus on Neoadjuvant Therapy for Breast Cancer: Linking Practice to Evidence and Beyond

2015 · C.E. Simmons, S. Hogeveen, et al. · Current Oncology · 18

PDF

A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM).

2019 · Mustafa Khasraw, Kerrie Leanne McDonald, et al. · Journal of Clinical Oncology · 11

Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention

2024 · Mona M Faris, Haryana M Dhillon, et al. · JNCI Cancer Spectrum · 7

PDF

What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry

2021 · Misa Matsuyama, Mythily Sachchithananthan, et al. · Neuro-Oncology Practice · 6

PDF

Barriers and potential solutions to international collaboration in neuro‐oncology clinical trials: Challenges from the Australian perspective

2021 · Benjamin Y. Kong, Candace Carter, et al. · Asia-Pacific Journal of Clinical Oncology · 6

PDF

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking

2019 · Craig Gedye, Mythily Sachchithananthan, et al. · Neuro-Oncology Practice · 5

PDF

Implementation and evaluation of a national quality improvement initiative in cancer surgery

2024 · Angel Arnaout, Shaheena Mukhi, et al. · BMJ Open Quality · 4

Physical activity and glioma: a case–control study with follow-up for survival

2022 · Zohreh Basiri, Yi Yang, et al. · Cancer Causes & Control · 3

PDF

Development of a practice consensus statement of the management of locally advanced breast cancer: Expert consensus and systematic review.

2013 · Robyn Leonard, Sophie Hogeveen, et al. · Journal of Clinical Oncology · 2

Implementing and Sustaining Early Cancer Diagnosis Initiatives in Canada: An Exploratory Qualitative Study

2021 · Christine Fahim, Larkin Davenport Huyer, et al. · Current Oncology · 1

A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY

2019 · Mustafa Khasraw, Kerrie L. McDonald, et al. · Own your potential (DEAKIN) · 1

ACTR-24. A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY

2019 · Mustafa Khasraw, Kerrie Leanne McDonald, et al. · Neuro-Oncology · 1

2019 · Hao-Wen Sim, Elizabeth Barnes, et al. · Journal of Clinical Oncology · 1

A randomized phase 2 trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM): Feasibility and safety outcomes (the VERTU study).

2018 · Mustafa Khasraw, Kerrie Leanne McDonald, et al. · Journal of Clinical Oncology · 1

Social media use amongst oncologists: Results of a national physician survey.

2014 · Rachel Adilman, Yanchini Rajmohan, et al. · Journal of Clinical Oncology · 1

Coordination of care in the context of primary brain tumors: Australian healthcare professionals’ exploration of the unspoken impact and clinical implications

2026 · Megan S. Jeon, Hannah Isaac, et al. · Supportive Care in Cancer

PDF

Eliminating cervical cancer in Canada is within reach

2026 · Riley Urquhart-Ducharme, Erica Dias, et al. · Canadian Journal of Public Health

PDF

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study

2023 · Meera R Agar, Anna K Nowak, et al. · BMJ Supportive & Palliative Care

Ctni-42. Genome-wide Dna Methylation Patterns in Vertu: a Randomized Phase Ii Trial of Veliparib, Radiotherapy and Temozolomide in Patients With Mgmt-unmethylated Glioblastoma

2022 · Hao-Wen Sim, Zarnie Lwin, et al. · Neuro-Oncology

PDF

Qolp-23. Phase Ii Randomised Placebo-controlled Double-blind Study of Acetazolamide Versus Placebo for Cerebral Oedema in Recurrent And/or Progressive High-grade Glioma Requiring Treatment With Dexamethasone

2020 · Meera Agar, Anna Nowak, et al. · Neuro-Oncology

PDF

Do care pathways help us choose wisely in the setting of neoadjuvant therapy for breast cancer? Results of a pre-post analysis.

2015 · Rachel Adilman, Dimas Yusuf, et al. · Journal of Clinical Oncology

An assessment of neoadjuvant therapy for breast cancer and treatment wait times at the BC Cancer Agency Vancouver.

2014 · Rachel Adilman, Robyn Leonard, et al. · Journal of Clinical Oncology

Works count: 29

Citation count: 225

H-index: 6

I10-index: 5